Bridging the Gap: Integrating Behavioral Health into Primary Care __________________________________
• Gamma-aminobutyric acid (GABA): An inhibitory neurotransmitter that reduces neuronal excitability and promotes relaxation. Deficiencies in GABA have been associated with anxiety disorders and epilepsy. Psychotropic medications work by targeting these neurotrans- mitter systems to restore balance and alleviate symptoms (Ern- stmeyer & Christman, 2022). They can do this by: • Increasing or decreasing neurotransmitter synthesis: Some medications affect the production of neurotransmitters. • Influencing neurotransmitter release: Some medications alter the release of neurotransmitters from neurons. • Blocking or enhancing neurotransmitter reuptake: Some medications block or enhance the reuptake of neurotransmitters, influencing their availability in the synapse (the space between neurons). • Acting on neurotransmitter receptors: Some medications directly bind to neurotransmitter receptors, activating or blocking them. Mechanism of Action of Psychotropic Medications Different classes of psychotropic medications have distinct mechanisms of action (Ernstmeyer & Christman, 2022): • Antidepressants: These medications primarily work by increasing the availability of serotonin, norepinephrine, or both in the brain. They achieve this through various mechanisms, including: ‒ Selective serotonin reuptake inhibitors (SSRIs) Block serotonin reuptake, increasing its concentration in the synapse. ‒ Serotonin-norepinephrine reuptake inhibitors (SNRIs): Block serotonin and norepinephrine reuptake. ‒ Tricyclic antidepressants (TCAs): Block the reuptake of serotonin and norepinephrine but also have effects on other neurotransmitter systems. ‒ Monoamine oxidase inhibitors (MAOIs): Inhibit the enzyme monoamine oxidase, which breaks down serotonin, norepinephrine, and dopamine. • Anxiolytics: These medications primarily
landscape of common psychotropic medications, including antidepressants, anxiolytics, mood stabilizers, and antipsy- chotics. This section offers a comprehensive overview of these medications, encompassing their indications, potential side effects, and critical prescribing considerations. We will then discuss the practical aspects of prescribing psy- chotropic medications, emphasizing careful consideration of starting doses, titration strategies, and ongoing monitoring for side effects. This module also highlights the importance of patient education, empowering individuals with the knowledge to participate actively in their treatment journey. Finally, we will equip healthcare professionals with practical strategies for managing medication side effects, addressing patient concerns, and recognizing when referral to a psychiatrist is necessary. This module provides a comprehensive guide to psychopharmacology in primary care, empowering healthcare professionals to make informed decisions and provide optimal care for individuals with mental health needs. 5.1 PRINCIPLES OF PSYCHOPHARMACOLOGY Psychopharmacology is the study of how medications affect mental processes and behavior. The multidisciplinary field draws on knowledge of neuroscience, pharmacology, psychol- ogy, and psychiatry. Understanding the underlying principles of psychopharmacology is crucial for safe and effective prescrib- ing in the primary care setting. Neurobiology of Mental Disorders Mental disorders are complex conditions that arise from genetic, environmental, and neurobiological factors (Teleanu et al., 2022). While the exact causes of most mental disor- ders remain unknown, research suggests that imbalances or dysfunctions in brain chemicals called neurotransmitters play a significant role. These neurotransmitters are chemical messengers that transmit signals between brain nerve cells (neurons). They regulate various brain functions, including mood, anxiety, sleep, appetite, and cognition. Key neurotransmitters involved in mental disorders include the following: • Serotonin: A neurotransmitter that regulates mood, sleep, appetite, and impulsivity. Low levels of serotonin have been linked to depression, anxiety disorders, and obsessive-compulsive disorder (OCD). • Dopamine: A neurotransmitter involved in motivation, reward, and movement. Imbalances in dopamine have been implicated in schizophrenia, attention-deficit/hyperactivity disorder (ADHD), and substance use disorders. • Norepinephrine: A neurotransmitter that plays a role in alertness, arousal, and stress response. Dysregulation of norepinephrine has been linked to anxiety disorders, depression, and post- traumatic stress disorder (PTSD).
enhance the activity of GABA, an inhibitory neurotransmitter that reduces anxiety. They achieve this through various mechanisms, including: ‒ Benzodiazepines: Bind to GABA receptors, enhancing GABA’s inhibitory effects.
156
EliteLearning.com/Psychology
Powered by FlippingBook